Breast cancer pathological image segmentation (BCPIS) holds significant value in assisting physicians with quantifying tumor regions and providing treatment guidance. However, achieving fine-grained semantic segmentation remains a major challenge for this technology. The complex and diverse morphologies of breast cancer tissue structures result in high costs for manual annotation, thereby limiting the sample size and annotation quality of the dataset. These practical issues have a significant impact on the segmentation performance. To overcome these challenges, this study proposes a semi-supervised learning model based on classification-guided segmentation. The model first utilizes a multi-scale convolutional network to extract rich semantic information and then employs a multi-expert cross-layer joint learning strategy, integrating a small number of labeled samples to iteratively provide the model with class-generated multi-cue pseudo-labels and real labels. Given the complexity of the breast cancer samples and the limited sample quantity, an innovative approach of augmenting additional unlabeled data was adopted to overcome this limitation. Experimental results demonstrate that, although the proposed model falls slightly behind supervised segmentation models, it still exhibits significant progress and innovation. The semi-supervised model in this study achieves outstanding performance, with an IoU (Intersection over Union) value of 71.53%. Compared to other semi-supervised methods, the model developed in this study demonstrates a performance advantage of approximately 3%. Furthermore, the research findings indicate a significant correlation between the classification and segmentation tasks in breast cancer pathological images, and the guidance of a multi-expert system can significantly enhance the fine-grained effects of semi-supervised semantic segmentation.
Keywords: Breast cancer; Deep learning model; Multi-expert system; Pathological images; Semi-supervised semantic segmentation.
© 2023. International Federation for Medical and Biological Engineering.